-
公开(公告)号:WO2021247544A1
公开(公告)日:2021-12-09
申请号:PCT/US2021/035212
申请日:2021-06-01
Applicant: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL , THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Inventor: PAPADOPOULOU, Virginie , DAYTON, Paul Alexander , CONLON, Sarah Elizabeth , CONLON, Brian Patrick , DURHAM, Phillip Gregory , BORDEN, Mark A.
IPC: A61N7/00 , A61B17/22 , A61M37/00 , A61K9/00 , A61K31/7012 , A61K31/201 , A61K38/14 , A61K31/7036 , A61B17/2202 , A61B2017/22008 , A61B2017/22088 , A61K49/223 , A61K9/0019 , A61L26/00
Abstract: A method for applying ultrasound to activate a cavitation enhancing agent in the presence of a therapeutic compound and a microbial biofilm is provided. The ultrasound energy causes the cavitation enhancing agent to cavitate in the ultrasound field. The cavitation of the resultant bubble causes fluid streaming and shear forces at and near the biofilm, causing enhanced penetration of the therapeutic compound into the biofilm, and resulting in improved efficacy of the therapeutic compound against the biofilm. The method further includes cavitation enhancing agents which can be loaded with oxygen gas or combined with microbubbles which carry oxygen gas, which further potentiate antibiotic efficacy against the biofilm.
-
公开(公告)号:WO2023273195A1
公开(公告)日:2023-01-05
申请号:PCT/CN2021/138003
申请日:2021-12-14
Applicant: 中国科学院深圳先进技术研究院
IPC: A61K49/22 , A61B8/08 , A61B8/481 , A61K49/221 , A61K49/223
Abstract: 一种双靶向肿瘤的超声分子复合成像方法,该方法利用肿瘤血管双靶向成像剂依次在软壳泡和硬壳泡临界声压下进行爆破,利用血池再灌注信号,分别得到两个靶向血池成像信号。肿瘤血管双靶向成像剂,包括两种壳硬度不同且能耐受不同超声声压阈值的超声造影剂;所述两种壳硬度不同且能耐受不同超声声压阈值的超声造影剂分别为软壳泡和硬壳泡。所述双靶向肿瘤的超声分子复合成像方法,能有效分离不同靶标的超声信号,为早期肿瘤的诊断、肿瘤所处阶段的血管化程度以及治疗效果的评估开辟了新的思路;能实现肿瘤血管生成过程无创性超声分子成像监测,为肿瘤的早期诊断、精准治疗甚至预测肿瘤的生物学行为提供重要帮助。
-
公开(公告)号:WO2022001254A1
公开(公告)日:2022-01-06
申请号:PCT/CN2021/084077
申请日:2021-03-30
Applicant: 南京超维景生物科技有限公司
IPC: A61K49/22 , A61K31/337 , A61K47/32 , A61K47/22 , A61K47/42 , A61K47/10 , A61P35/00 , A61K49/223
Abstract: 一种超声造影剂组合物、超声造影剂及其制备方法。该超声造影剂组合物包括脂质、稳定剂和声致形变材料,相对于100重量份的脂质,稳定剂的含量为20-100重量份,声致形变材料的含量为1-15重量份;其中声致形变材料为能够在特定声波条件下发生形变的材料,所述声致形变材料的特征响应频率为0.01MHz-50MHz。该超声造影剂组合物得到的微泡超声造影剂具有较好的稳定性,从而能够在体内循环较长的时间,同时具有较低的机械指数,从而能够在低能量超声波下发生惯性空化;因此该超声造影剂组合物得到的微泡超声造影剂能够在同一超声成像探头作用下同时充当造影剂和药物递送剂。
-
公开(公告)号:WO2022034176A2
公开(公告)日:2022-02-17
申请号:PCT/EP2021/072510
申请日:2021-08-12
Inventor: QIU, Tian , FISCHER, Peer
IPC: A61K9/50 , A61K49/04 , A61K49/18 , A61K49/22 , A61K51/12 , B32B15/02 , C09B67/02 , A61K49/0419 , A61K49/1818 , A61K49/223 , A61K51/1265 , A61K9/5094 , C09B67/0097
Abstract: The invention relates to a delivery device formed by an aggregation of a plurality of individual particles in a host fluid, wherein one or more individual particles of the plurality of individual particles has a density of less than the host fluid, preferably less than water, and a bonding property which permits the initially separate individual particles to aggregate in said host fluid, i.e. to be connected one to another in said host fluid, to form the aggregation. The invention further relates to a method for producing a plurality of individual particles and to a method of forming a delivery device from a plurality of particles in a host fluid at an aggregation site.
-
公开(公告)号:WO2022001255A1
公开(公告)日:2022-01-06
申请号:PCT/CN2021/084087
申请日:2021-03-30
Applicant: 南京超维景生物科技有限公司
IPC: A61K49/22 , A61K49/00 , A61K41/00 , A61K9/06 , B82Y40/00 , B82Y20/00 , B82Y5/00 , A61K41/0057 , A61K41/0071 , A61K49/0002 , A61K49/223 , A61K49/226
Abstract: 涉及生物医药领域,具体涉及一种造影剂成膜剂组合物、含有该造影剂成膜剂组合物的造影剂成膜脂液,含有该造影剂成膜脂液的造影剂及其制备方法。该造影剂成膜剂组合物包括脂质、乳化剂和表面电荷修饰剂,相对于100重量份的所述脂质,所述乳化剂的含量为20-50重量份,所述表面电荷修饰剂的含量为10-35重量份;其中,所述脂质为羧基化的磷脂,所述表面电荷修饰剂为聚电解质。组合物和制备方法能够使得所得的造影剂的纳米液滴具有更均一的粒径、更高的稳定性和更好的可控性,并且具有更低的超声气化阈值,还能够用作光声造影剂或多模态造影剂,具有广阔的应用前景。
-
公开(公告)号:WO2022001253A1
公开(公告)日:2022-01-06
申请号:PCT/CN2021/084076
申请日:2021-03-30
Applicant: 南京超维景生物科技有限公司
IPC: A61K49/22 , A61K41/00 , A61K31/337 , A61P35/00 , A61K49/223
Abstract: 一种磁性超声造影剂组合物、磁性超声造影剂、磁性微泡超声造影剂及其制备方法。该磁性超声造影剂组合物包括脂质、表面活性剂和磁性纳米颗粒,其中,表面活性剂由表面活性A剂和表面活性B剂组成,表面活性A剂呈游离态,表面活性B剂呈结合态修饰于磁性纳米颗粒的表面;表面活性A剂HLB值>8;相对于1mol的所述脂质,表面活性A剂的含量为0.1-1mol,表面活性B剂的含量为0.1-1mol,磁性纳米颗粒的含量为0.05-0.5mol。磁性超声造影剂组合物所得到的磁性微泡超声造影剂具有较高的稳定性,能够满足体内循环靶向递送的要求,从而实现药物的局部高浓度靶向递送。
-
-
-
-
-